Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

Cancer: Drugs

Department of Health written question – answered on 7th June 2016.

Alert me about debates like this

Photo of Nick Brown Nick Brown Chair, Finance Committee (Commons)

To ask the Secretary of State for Health, for what reasons the Lutathera drug was removed from the list of drugs available under the Cancer Drugs Fund.

Photo of George Freeman George Freeman The Parliamentary Under-Secretary of State for Business, Innovation and Skills, The Parliamentary Under-Secretary of State for Health

Peptide receptor radionuclide therapy (including Luththera) for the treatment of gastro-entero-pancreatic neuroendocrine tumours was removed from the Cancer Drugs Fund in November 2015 on the grounds that it represented insufficient value for retention within the Fund.

NHS England’s full decision summary is available at:

https://www.england.nhs.uk/ourwork/cancer/cdf/cdf-drug-sum/

Does this answer the above question?

Yes0 people think so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.